Will desloratadine's approval -- coming just in time for the spring allergy season -- help to propel its use to the levels enjoyed by Claritin? Will the clinical advantages and lower price of ...

Schering has, however, already received a broader range of approvals for desloratadine than it has for loratadine. Both medications are indicated for seasonal allergic rhinitis and chronic ...